| PATENT REGISTER | |||||||||||||||||||||||||||||
| A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2009/015 | |||||||||||||||||||||||||||||
| Status | Expired | Patent No. | 1309692 | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Application No. | 01959598.2 | Date of Filing | 07/08/2001 | ||||||||||||||||||||||||||
| Date Grant Published | 13/05/2009 | Application Published | 14/05/2003 | ||||||||||||||||||||||||||
| Title of Invention | ANTI-IL-12 ANTIBODIES, COMPOSITIONS, METHODS AND USES | ||||||||||||||||||||||||||||
| Priority |
|
||||||||||||||||||||||||||||
| Inventors |
GILES-KOMAR, Jill KNIGHT, David, M. PERITT, David SCALLON, Bernard SHEALY, David |
||||||||||||||||||||||||||||
| Current Proprietor |
Janssen Biotech, Inc. 800/850 Ridgeway Drive Horsham, PA 19044 UNITED STATES OF AMERICA |
||||||||||||||||||||||||||||
| Address for service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||||||||||||||||||||||||||||
| Renewal Fees |
|
||||||||||||||||||||||||||||
| Publication Language | English | ||||||||||||||||||||||||||||
| Translation Received Date | |||||||||||||||||||||||||||||
| 26/05/2009 | Address for Service recorded as FRKelly 27 Clyde Road, Ballsbridge, Ireland received on 25/05/2009. | ||||||||||||||||||||||||||||
| 28/05/2009 | Request for grant a Supplementary Protection Certificate, citing Patent number 1309692 as the relevant basic patent, in respect of the product Ustekinumab filed on 14/05/2009. Reference number of request is 2009/015. | ||||||||||||||||||||||||||||
| 25/06/2009 | Divisional Application number: 09006396.7 Date of receipt: 12/05/2009 | ||||||||||||||||||||||||||||
| 02/05/2013 | Supplementary Protection Certificate Number 2009/015, having an expiry date of 15/01/2024 granted on 02/05/2013. | ||||||||||||||||||||||||||||
| 01/12/2014 | Change of name and address of proprietor from CENTOCOR, INC., 200 Great Valley Parkway, Malvern, PA 19355, United States of America to Janssen Biotech, Inc., 800/850 Ridgeway Drive, Horsham, PA 19044, United States of America recorded on 28/11/2014. | ||||||||||||||||||||||||||||
| 07/11/2016 | The expiry date of SPC No. 2009/015 has been amended to bring it into line with the decision from the Court of Justice of the European Union in Case C-471/14. New expiry date is 19/01/2024. | ||||||||||||||||||||||||||||
| 16/03/2020 | Application for an extension of the duration of Supplementary Protection Certificate No. 2009/015 filed on 12/03/2020. | ||||||||||||||||||||||||||||
| 24/11/2020 | Application for an extension of the duration of Supplementary Protection Certificate No. 2009/015 granted on 24/11/2020. Expiry date of SPC changed from 19/01/2024 to 19/07/2024. | ||||||||||||||||||||||||||||
| 01/09/2021 | Patent expired on 06/08/2021. | ||||||||||||||||||||||||||||
